You have 9 free searches left this month | for more free features.

City

Boston (2)

Aurora (1)

Baltimore (1)

Helsinki (1)

Indianapolis (1)

New York (1)

Salt Lake City (1)

Condition

Multiple Myeloma (1)

Multiple Myeloma in Relapse (1)

Solid Tumor (1)

Waldenstrom's Macroglobulinemia (1)

Overall Status

Active, not recruiting (1)

No longer available (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (2)

Sponsor

Dana-Farber Cancer Institute (2)

Bristol-Myers Squibb (1)

Collaborator

Bristol-Myers Squibb (2)

Intervention

ulocuplumab (3)

bortezomib (1)

dexamethasone (1)

ibrutinib (1)

lenalidomide (1)

nivolumab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Expanded Access (1)

ulocuplumab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

Active, not recruiting

Waldenstrom's Macroglobulinemia

Ulocuplumab
Ibrutinib

Boston, Massachusetts

Dana Farber Cancer Institute

Jun 20, 2022

Solid Tumor Trial in Finland, United States (Ulocuplumab, Nivolumab)

Terminated

Has Results

Solid Tumor

Ulocuplumab
Nivolumab

Aurora, Colorado
+6 more

Oct 5, 2018

Multiple Myeloma in Relapse, Multiple Myeloma Trial in Boston (Ulocuplumab, Lenalidomide, Bortezomib)

No longer available

Multiple Myeloma in Relapse
Multiple Myeloma

Ulocuplumab
+3 more

Boston, Massachusetts

Dana Farber Cancer Institute

Aug 25, 2017